Prestige Biologics Co., Ltd. announced a private placement of 13,787,830 shares at a share price of KRW 500 per share for the gross proceeds of KRW 6,893,915,000? on August 26, 2022. The expected payment date is September 5, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7,980 KRW | 0.00% | -1.48% | -15.82% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
7,980 KRW | 0.00% | -1.48% | 70.14M | ||
4,125 KRW | +0.24% | -0.12% | 185M | ||
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.82% | 70.14M | |
-2.47% | 89.37B | |
+2.76% | 40.65B | |
-12.22% | 32.81B | |
+52.41% | 25B | |
-17.36% | 15.29B | |
-42.45% | 11.61B | |
-10.48% | 11.49B | |
+6.14% | 8.98B | |
-7.72% | 8.23B |
- Stock Market
- Equities
- A950210 Stock
- News Prestige BioPharma Limited
- Prestige Biologics Co., Ltd. announced that it expects to receive KRW 6.893915 billion in funding from Prestige BioPharma Limited